Asia-Pacific Mammography Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 521.17 Million |
| Market Size (2029) | USD 834.41 Million |
| CAGR (2024 - 2029) | 9.87 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Asia-Pacific Mammography Market Analysis
The Asia-Pacific Mammography Market size is estimated at USD 521.17 million in 2024, and is expected to reach USD 834.41 million by 2029, growing at a CAGR of 9.87% during the forecast period (2024-2029).
The major factors contributing to the growth of the Asia-Pacific mammography market are the rising incidence of breast cancer, large R&D investment in breast cancer therapies, and advances in breast imaging modalities. In most Asian countries, breast cancer is the most common cancer. Incidence rates increase at a faster rate than in Western countries due to lifestyle and dietary changes. The Center for Disease Control (CDC) reports breast cancer to be one of the most common cancers among women, irrespective of race or ethnicity. The rising prevalence of breast cancer and the growing healthcare infrastructure in the region is expected to drive the overall growth. As per the GLOBOCAN 2018, the estimated age-standardized incidence rate of breast cancer in Asia is 34.4 per 100,00. The other factors helping the growth of the mammography market are the rapid increase in population.
Asia-Pacific Mammography Market Trends
This section covers the major market trends shaping the APAC Mammography Market according to our research experts:
Digital Mammography Segment is Expected to Hold the Largest Market Share in the Asia-Pacifc Mammography Market
Digital mammography is a specialized and advanced form of mammography that uses digital receptors and computers instead of X-ray films to examine breast tissue for tumor presence. So far, conventional screen-film mammography (SFM) with high-spatial-resolution has been the preferred choice for screening programs in most countries. However, with the advent of digital mammography, an increasing number of countries are experiencing shifts toward these newer systems, due to their superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts. They also come with an added advantage of soft-copy image displays and soft-copy reading, which can be easily transferred. Mammography screening offers greater precision, better quality, and higher efficiency results. Thus, digital mammography is becoming the preferred choice of selection, even though the new technology cost is six times higher than the conventional systems. These factors are expected to contribute to the growth of the market during the forecast period.
Asia-Pacific Mammography Industry Overview
The Asia-Pacific mammography market is competitive and consists of several players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions across the region. Some of the companies which are currently dominating the market are Bayer AG, Pfizer Inc., Merck & Co., Inc., CooperSurgical, Inc., and Allergan PLC.
Asia-Pacific Mammography Market Leaders
-
Fujifilm Holdings Corporation
-
GE Healthcare
-
Hologic Inc.
-
Koninklijke Philips N.V.
-
Siemens Healthineers AG
*Disclaimer: Major Players sorted in no particular order
Asia-Pacific Mammography Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Incidences of Breast Cancer
- 4.2.2 Advancements in the Technologies of Breast Imaging Modalities
-
4.3 Market Restraints
- 4.3.1 High Cost of Imaging Devices
- 4.3.2 Risk of Adverse Effects of Radiation Exposure
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Product Type
- 5.1.1 Digital Systems
- 5.1.2 Analog Systems
- 5.1.3 Breast Tomosynthesis
- 5.1.4 Film Screen Systems
- 5.1.5 Other Product Types
-
5.2 By End Users
- 5.2.1 Hospitals
- 5.2.2 Diagnostic Centers
- 5.2.3 Others
-
5.3 Geography
- 5.3.1 Asia-Pacific
- 5.3.1.1 China
- 5.3.1.2 Japan
- 5.3.1.3 India
- 5.3.1.4 Australia
- 5.3.1.5 South korea
- 5.3.1.6 Rest of Asia-Pacific
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Fujifilm Holdings Corporation
- 6.1.2 Hologic, Inc.
- 6.1.3 Koninklijke Philips N.V.
- 6.1.4 Siemens Healthineers AG
- 6.1.5 GE Healthcare
- 6.1.6 Metaltronica S.p.A.
- 6.1.7 Planmed Oy
- 6.1.8 Konica Minolta, Inc.
- 6.1.9 Carestream Health
- 6.1.10 Canon Medical Systems Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Asia-Pacific Mammography Industry Segmentation
In basic terms, mammography refers to a standard diagnostic and screening technique used to screen breast tissues to check the presence of a malignant tumor. The process involves the usage of low-energy X-rays for early detection of breast cancer.
| By Product Type | Digital Systems | |
| Analog Systems | ||
| Breast Tomosynthesis | ||
| Film Screen Systems | ||
| Other Product Types | ||
| By End Users | Hospitals | |
| Diagnostic Centers | ||
| Others | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South korea | ||
| Rest of Asia-Pacific |
Asia-Pacific Mammography Market Research FAQs
How big is the Asia-Pacific Mammography Market?
The Asia-Pacific Mammography Market size is expected to reach USD 521.17 million in 2024 and grow at a CAGR of 9.87% to reach USD 834.41 million by 2029.
What is the current Asia-Pacific Mammography Market size?
In 2024, the Asia-Pacific Mammography Market size is expected to reach USD 521.17 million.
Who are the key players in Asia-Pacific Mammography Market?
Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips N.V. and Siemens Healthineers AG are the major companies operating in the Asia-Pacific Mammography Market.
What years does this Asia-Pacific Mammography Market cover, and what was the market size in 2023?
In 2023, the Asia-Pacific Mammography Market size was estimated at USD 474.35 million. The report covers the Asia-Pacific Mammography Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Mammography Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Asia Pacific Mammography Industry Report
Statistics for the 2024 Asia Pacific Mammography market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia Pacific Mammography analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
